SLC22A1 and lactic acidosis: Furthermore, genetic variations in the SLC22A1 gene encoding OCT1 were associated with altered pharmacokinetics and pharmacodynamics of metformin [122,123], which might pose a higher risk for side effects of metformin, especially lactic acidosis ([86], for review see [124]).